WEBINAR: Evidence-Based Strategy in the Prevention of Complications due to Retained Blood

October 20, 2023 at 11:00 AM Eastern/8:00 AM Pacific

Industry experts will discuss the latest research, evidence-based strategies, and best practices in preventing complications associated with retained blood to help enhance patient care and safety for a significant impact in healthcare settings.

PleuraFlow ACT in Your Hospital

PleuraFlow ACT

PleuraFlow® Active Clearance Technology® (ACT) is a unique system that proactively removes clots formed inside the chest tube to prevent or minimize chest tube occlusion. A patent chest tube enables evacuation of blood and fluid from the operative site after closure of the surgical wound and reduces retained blood.

Magnet Strength Button
Additional power on demand
Sophisticated New Magnetic Array
Designed to overcome the most stubborn occlusions
Guide Tube
Connects to any drainage canister
Clearance Wire & Loop
Maintains chest tube patency

Trusted in Top Cardiac Institutions

“I am convinced that blood orphaned in the thoracic space after cardiac surgery can cause not only the acute problems we all see, but also more pernicious and chronic inflammatory consequences that affect many organs detrimentally. It is vital that chest drain patency is maintained in the first 24 hours after surgery and there is no better way to do that than PleuraFlow.”

Jill Ley, RN, MS, CNS
Clinical Nurse Specialist, Cardiac Surgery
California Pacific Medical Center
Clinical Professor, UCSF


The Proven Way of Maintaining Chest Tube Patency

Each photo below shows clogged conventional tubes and clear PleuraFlow ACT tubes removed from the same patients 24-48 hours post cardiothoracic surgery.


PleuraFlow ACT is Easy to Use

Connects to Any Drainage Canister